Cox John

CEO & President at DYN; Director at RGEN; EVP Pharmaceutical Oper & Tech at BIIB

Sold, on record
$15.3M
Dollars the filings state
Form 4 sales
24
Latest Sep 8, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

  • DYNDyne Therapeutics, Inc.CEO & President
  • RGENREPLIGEN CORPDirector
  • BIIBBIOGEN INC.EVP Pharmaceutical Oper & Tech

Sales by reason

6
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale DYNRoutine
    Jun 5 2025

    Sold 4,060 shares at $13.35 ($54k)

    Cox John, CEO & President

    10b5-1 planSold 2.8% of holdings ($2M position)142,179 shares leftFiling

  2. 2 Form 4 sale DYNRoutine
    Sep 5 +92 days

    Sold 2,640 shares at $13.41 ($35k)

    Cox John, CEO & President

    10b5-1 planSold 1.3% of holdings ($2.7M position)199,539 shares leftFiling

  3. 3 Form 4 sale DYNRoutine
    Dec 5 +91 days

    Sold 2,662 shares at $20.72 ($55k)

    Cox John, CEO & President

    10b5-1 planSold 1.3% of holdings ($4.1M position)196,877 shares left0.7x usual sizeFiling

  4. 4 Form 4 sale DYNRoutine
    Mar 5 +90 days

    Sold 2,732 shares at $14.90 ($41k)

    Cox John, CEO & President

    10b5-1 planSold 0.7% of holdings ($5.6M position)374,145 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale DYNRoutine
    May 13 +69 days

    Sold 3,311 shares at $18.36 ($61k)

    Cox John, CEO & President

    10b5-1 planSold 0.9% of holdings ($6.9M position)370,834 shares left1.2x usual sizeFiling

  6. 6 Form 4 sale DYNRoutine
    Jun 16 +34 days

    Sold 2,683 shares at $18.33 ($49k)

    Cox John, CEO & President

    10b5-1 planSold 0.7% of holdings ($6.8M position)368,151 shares left0.9x usual sizeFiling

  7. 7 Form 4 sale DYNRoutine
    Aug 13 +58 days

    Sold 4,986 shares at $26.28 ($131k)

    Cox John, CEO & President

    10b5-1 planSold 1.4% of holdings ($9.7M position)363,165 shares left1.8x usual sizeFiling

  8. 8 Form 4 sale DYNRoutine
    Sep 8 +26 days

    Sold 5,658 shares at $18.88 ($107k)

    Cox John, CEO & President

    10b5-1 planSold 1.6% of holdings ($6.9M position)357,507 shares left1.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (24)

Form 144 notices and Form 4 sales by Cox John
Source
Sep 8, 2026DYNCEO & PresidentForm 4 sale5,658$107k1.6%RoutineSEC
Aug 13, 2026DYNCEO & PresidentForm 4 sale4,986$131k1.4%RoutineSEC
Jun 16, 2026DYNCEO & PresidentForm 4 sale2,683$49k0.7%RoutineSEC
May 13, 2026DYNCEO & PresidentForm 4 sale3,311$61k0.9%RoutineSEC
Mar 5, 2026DYNCEO & PresidentForm 4 sale2,732$41k0.7%RoutineSEC
Dec 5, 2025DYNCEO & PresidentForm 4 sale2,662$55k1.3%RoutineSEC
Sep 5, 2025DYNCEO & PresidentForm 4 sale2,640$35k1.3%RoutineSEC
Jun 5, 2025DYNCEO & PresidentForm 4 sale4,060$54k2.8%RoutineSEC
Mar 5, 2025DYNCEO & PresidentForm 4 sale4,061$48k2.7%RoutineSEC
Mar 24, 2020RGENDirectorForm 4 sale1,858$180k66.8%UnusualSEC
Mar 18, 2020RGENDirectorForm 4 sale26,736$2.5M90.6%UnusualSEC
Mar 4, 2020RGENDirectorForm 4 sale10,000$934k78.2%UnusualSEC
Feb 24, 2020RGENDirectorForm 4 sale4,455$413k61.6%UnusualSEC
Mar 25, 2015BIIBEVP Pharmaceutical Oper & TechForm 4 sale12,010$5.4M32.0%UnusualSEC
Nov 1, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale2,175$249k18.5%Plan not statedSEC
Apr 21, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale4,350$435k29.6%UnusualSEC
Apr 13, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale36,234$2.9M77.8%UnusualSEC
Apr 11, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale6,900$538k40.0%UnusualSEC
Mar 31, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale2,840$207k22.4%Plan not statedSEC
Mar 2, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale4,041$283k29.2%UnusualSEC
Feb 17, 2011BIIBEVP Pharmaceutical Oper & TechForm 4 sale1,843$124k11.9%Plan not statedSEC
Nov 9, 2010BIIBEVP Pharmaceutical Oper & TechForm 4 sale773$49k4.5%Plan not statedSEC
Nov 2, 2010BIIBEVP Pharmaceutical Oper & TechForm 4 sale765$48k4.3%Plan not statedSEC
Oct 28, 2010BIIBEVP Pharmaceutical Oper & TechForm 4 sale6,900$435k27.4%UnusualSEC